"Candidiasis, Oral" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Infection of the mucous membranes of the mouth by a fungus of the genus CANDIDA. (Dorland, 27th ed)
Descriptor ID |
D002180
|
MeSH Number(s) |
C01.703.160.180 C07.465.130
|
Concept/Terms |
Candidiasis, Oral- Candidiasis, Oral
- Candidiases, Oral
- Oral Candidiases
- Oral Candidiasis
- Thrush
- Moniliasis, Oral
- Moniliases, Oral
- Oral Moniliases
- Oral Moniliasis
|
Below are MeSH descriptors whose meaning is more general than "Candidiasis, Oral".
Below are MeSH descriptors whose meaning is more specific than "Candidiasis, Oral".
This graph shows the total number of publications written about "Candidiasis, Oral" by people in this website by year, and whether "Candidiasis, Oral" was a major or minor topic of these publications.
View timeline visualization
Year | Major Topic | Minor Topic | Total |
---|
1995 | 1 | 0 | 1 |
1996 | 1 | 2 | 3 |
1997 | 3 | 2 | 5 |
1998 | 2 | 1 | 3 |
1999 | 1 | 0 | 1 |
2000 | 3 | 2 | 5 |
2001 | 1 | 2 | 3 |
2002 | 2 | 6 | 8 |
2003 | 1 | 1 | 2 |
2004 | 1 | 1 | 2 |
2005 | 2 | 0 | 2 |
2006 | 1 | 3 | 4 |
2008 | 1 | 1 | 2 |
2009 | 3 | 1 | 4 |
2010 | 2 | 0 | 2 |
2011 | 0 | 3 | 3 |
2012 | 4 | 1 | 5 |
2013 | 1 | 1 | 2 |
2014 | 2 | 0 | 2 |
2016 | 3 | 0 | 3 |
2017 | 4 | 0 | 4 |
2018 | 1 | 0 | 1 |
2019 | 1 | 0 | 1 |
2020 | 2 | 0 | 2 |
2021 | 2 | 1 | 3 |
2022 | 2 | 0 | 2 |
2023 | 4 | 1 | 5 |
2024 | 0 | 1 | 1 |
Below are the most recent publications written about "Candidiasis, Oral" by people in Profiles.
-
Common Oral Conditions: A Review. JAMA. 2024 03 26; 331(12):1045-1054.
-
IκBζ is an essential mediator of immunity to oropharyngeal candidiasis. Cell Host Microbe. 2023 10 11; 31(10):1700-1713.e4.
-
Candida albicans stimulates formation of a multi-receptor complex that mediates epithelial cell invasion during oropharyngeal infection. PLoS Pathog. 2023 08; 19(8):e1011579.
-
Identification and susceptibility testing of oral candidiasis in advanced cancer patients. BMC Oral Health. 2023 04 18; 23(1):223.
-
Oral complications in a paediatric graft versus host disease (GVHD) clinic: A retrospective study. Oral Dis. 2024 04; 30(3):1084-1090.
-
Candida albicans Oropharyngeal Infection Is an Exception to Iron-Based Nutritional Immunity. mBio. 2023 04 25; 14(2):e0009523.
-
Safety and Efficacy of Bimekizumab in Patients With Active Psoriatic Arthritis: Three-Year Results From a Phase IIb Randomized Controlled Trial and Its Open-Label Extension Study. Arthritis Rheumatol. 2022 12; 74(12):1959-1970.
-
Systematic Genetic Interaction Analysis Identifies a Transcription Factor Circuit Required for Oropharyngeal Candidiasis. mBio. 2022 02 22; 13(1):e0344721.
-
The Globular C1q Receptor Is Required for Epidermal Growth Factor Receptor Signaling during Candida albicans Infection. mBio. 2021 12 21; 12(6):e0271621.
-
Bimekizumab versus Adalimumab in Plaque Psoriasis. N Engl J Med. 2021 07 08; 385(2):130-141.